nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP2E1—Fingolimod—multiple sclerosis	0.134	0.269	CbGbCtD
Fluphenazine—CYP2D6—Fingolimod—multiple sclerosis	0.0639	0.128	CbGbCtD
Fluphenazine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0631	0.127	CbGbCtD
Fluphenazine—ABCB1—Methylprednisolone—multiple sclerosis	0.0437	0.0878	CbGbCtD
Fluphenazine—CYP2E1—Dexamethasone—multiple sclerosis	0.0327	0.0657	CbGbCtD
Fluphenazine—ABCB1—Mitoxantrone—multiple sclerosis	0.0319	0.0641	CbGbCtD
Fluphenazine—ABCB1—Betamethasone—multiple sclerosis	0.0284	0.0571	CbGbCtD
Fluphenazine—ABCB1—Prednisolone—multiple sclerosis	0.028	0.0563	CbGbCtD
Fluphenazine—ABCB1—Prednisone—multiple sclerosis	0.0265	0.0532	CbGbCtD
Fluphenazine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0193	0.122	CbGeAlD
Fluphenazine—ABCB1—Dexamethasone—multiple sclerosis	0.0165	0.0332	CbGbCtD
Fluphenazine—CYP2D6—Dexamethasone—multiple sclerosis	0.0156	0.0313	CbGbCtD
Fluphenazine—Psychotic behaviour—Methylprednisolone—multiple sclerosis	0.0148	0.0996	CcSEcCtD
Fluphenazine—ABCB1—Methotrexate—multiple sclerosis	0.0133	0.0267	CbGbCtD
Fluphenazine—CALM1—trigeminal nerve—multiple sclerosis	0.00833	0.0525	CbGeAlD
Fluphenazine—CALM2—pons—multiple sclerosis	0.00589	0.0371	CbGeAlD
Fluphenazine—CALM1—pons—multiple sclerosis	0.00586	0.037	CbGeAlD
Fluphenazine—HTR2A—trigeminal nerve—multiple sclerosis	0.00507	0.032	CbGeAlD
Fluphenazine—DRD1—nerve—multiple sclerosis	0.00475	0.03	CbGeAlD
Fluphenazine—CALM2—pineal body—multiple sclerosis	0.0042	0.0265	CbGeAlD
Fluphenazine—CALM1—pineal body—multiple sclerosis	0.00419	0.0264	CbGeAlD
Fluphenazine—CALM2—peripheral nervous system—multiple sclerosis	0.00392	0.0247	CbGeAlD
Fluphenazine—CALM1—peripheral nervous system—multiple sclerosis	0.0039	0.0246	CbGeAlD
Fluphenazine—Pigmentation skin—Prednisone—multiple sclerosis	0.00386	0.026	CcSEcCtD
Fluphenazine—Liver injury—Fingolimod—multiple sclerosis	0.00377	0.0254	CcSEcCtD
Fluphenazine—HTR2A—pons—multiple sclerosis	0.00357	0.0225	CbGeAlD
Fluphenazine—CALM2—nerve—multiple sclerosis	0.00305	0.0193	CbGeAlD
Fluphenazine—CALM1—nerve—multiple sclerosis	0.00304	0.0192	CbGeAlD
Fluphenazine—DRD2—nerve—multiple sclerosis	0.00281	0.0177	CbGeAlD
Fluphenazine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00279	0.0176	CbGeAlD
Fluphenazine—Eczema—Fingolimod—multiple sclerosis	0.00256	0.0173	CcSEcCtD
Fluphenazine—HTR2A—pineal body—multiple sclerosis	0.00255	0.0161	CbGeAlD
Fluphenazine—HTR2A—peripheral nervous system—multiple sclerosis	0.00238	0.015	CbGeAlD
Fluphenazine—Hypotensive—Dexamethasone—multiple sclerosis	0.00222	0.015	CcSEcCtD
Fluphenazine—Hypotensive—Betamethasone—multiple sclerosis	0.00222	0.015	CcSEcCtD
Fluphenazine—Cardiac arrest—Fingolimod—multiple sclerosis	0.00219	0.0148	CcSEcCtD
Fluphenazine—Blood disorder—Cladribine—multiple sclerosis	0.00215	0.0145	CcSEcCtD
Fluphenazine—Pigmentation disorder—Prednisone—multiple sclerosis	0.00211	0.0142	CcSEcCtD
Fluphenazine—DRD1—brainstem—multiple sclerosis	0.00204	0.0129	CbGeAlD
Fluphenazine—HTR2A—nerve—multiple sclerosis	0.00185	0.0117	CbGeAlD
Fluphenazine—Pneumonia—Fingolimod—multiple sclerosis	0.00178	0.012	CcSEcCtD
Fluphenazine—Menstruation irregular—Prednisolone—multiple sclerosis	0.00175	0.0118	CcSEcCtD
Fluphenazine—Liver injury—Azathioprine—multiple sclerosis	0.00174	0.0117	CcSEcCtD
Fluphenazine—Jaundice cholestatic—Azathioprine—multiple sclerosis	0.00166	0.0112	CcSEcCtD
Fluphenazine—CALM3—retina—multiple sclerosis	0.00161	0.0102	CbGeAlD
Fluphenazine—Menstruation irregular—Triamcinolone—multiple sclerosis	0.00161	0.0109	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Triamcinolone—multiple sclerosis	0.00161	0.0109	CcSEcCtD
Fluphenazine—Menstruation irregular—Methylprednisolone—multiple sclerosis	0.00161	0.0108	CcSEcCtD
Fluphenazine—HTR2C—brainstem—multiple sclerosis	0.00159	0.00999	CbGeAlD
Fluphenazine—DRD3—nervous system—multiple sclerosis	0.00149	0.00941	CbGeAlD
Fluphenazine—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00146	0.00987	CcSEcCtD
Fluphenazine—Menstruation irregular—Dexamethasone—multiple sclerosis	0.00146	0.00986	CcSEcCtD
Fluphenazine—Menstruation irregular—Betamethasone—multiple sclerosis	0.00146	0.00986	CcSEcCtD
Fluphenazine—DRD3—central nervous system—multiple sclerosis	0.00144	0.00906	CbGeAlD
Fluphenazine—HTR6—nervous system—multiple sclerosis	0.00144	0.00906	CbGeAlD
Fluphenazine—Renal failure acute—Cladribine—multiple sclerosis	0.00141	0.00954	CcSEcCtD
Fluphenazine—HTR6—central nervous system—multiple sclerosis	0.00138	0.00872	CbGeAlD
Fluphenazine—HTR1A—brainstem—multiple sclerosis	0.00133	0.00841	CbGeAlD
Fluphenazine—Lethargy—Cladribine—multiple sclerosis	0.00133	0.00899	CcSEcCtD
Fluphenazine—CALM2—brainstem—multiple sclerosis	0.00131	0.00827	CbGeAlD
Fluphenazine—Dermatitis atopic—Prednisolone—multiple sclerosis	0.00131	0.00884	CcSEcCtD
Fluphenazine—Vision blurred—Fingolimod—multiple sclerosis	0.00131	0.00882	CcSEcCtD
Fluphenazine—CALM1—brainstem—multiple sclerosis	0.00131	0.00823	CbGeAlD
Fluphenazine—DRD1—midbrain—multiple sclerosis	0.0013	0.0082	CbGeAlD
Fluphenazine—Glaucoma—Prednisolone—multiple sclerosis	0.00129	0.00869	CcSEcCtD
Fluphenazine—Menstruation irregular—Prednisone—multiple sclerosis	0.00127	0.00859	CcSEcCtD
Fluphenazine—CALM2—retina—multiple sclerosis	0.00127	0.00798	CbGeAlD
Fluphenazine—CALM1—retina—multiple sclerosis	0.00126	0.00794	CbGeAlD
Fluphenazine—Leukopenia—Fingolimod—multiple sclerosis	0.00124	0.00838	CcSEcCtD
Fluphenazine—DRD2—brainstem—multiple sclerosis	0.00121	0.0076	CbGeAlD
Fluphenazine—Dermatitis atopic—Triamcinolone—multiple sclerosis	0.0012	0.00813	CcSEcCtD
Fluphenazine—Hypertension—Fingolimod—multiple sclerosis	0.0012	0.00808	CcSEcCtD
Fluphenazine—Glaucoma—Triamcinolone—multiple sclerosis	0.00118	0.00799	CcSEcCtD
Fluphenazine—Appetite absent—Methotrexate—multiple sclerosis	0.00118	0.00799	CcSEcCtD
Fluphenazine—Glaucoma—Methylprednisolone—multiple sclerosis	0.00118	0.00797	CcSEcCtD
Fluphenazine—CALM3—medulla oblongata—multiple sclerosis	0.00116	0.00734	CbGeAlD
Fluphenazine—DRD2—retina—multiple sclerosis	0.00116	0.00733	CbGeAlD
Fluphenazine—DRD3—brain—multiple sclerosis	0.00114	0.0072	CbGeAlD
Fluphenazine—Eosinophilia—Cladribine—multiple sclerosis	0.00112	0.00754	CcSEcCtD
Fluphenazine—HTR2C—medulla oblongata—multiple sclerosis	0.00111	0.00697	CbGeAlD
Fluphenazine—Skin disorder—Fingolimod—multiple sclerosis	0.0011	0.00742	CcSEcCtD
Fluphenazine—HTR6—brain—multiple sclerosis	0.0011	0.00693	CbGeAlD
Fluphenazine—Glaucoma—Dexamethasone—multiple sclerosis	0.00107	0.00725	CcSEcCtD
Fluphenazine—Glaucoma—Betamethasone—multiple sclerosis	0.00107	0.00725	CcSEcCtD
Fluphenazine—Pancytopenia—Cladribine—multiple sclerosis	0.00107	0.00723	CcSEcCtD
Fluphenazine—DRD1—nervous system—multiple sclerosis	0.00107	0.00674	CbGeAlD
Fluphenazine—CALM3—midbrain—multiple sclerosis	0.00106	0.00671	CbGeAlD
Fluphenazine—Hypotension—Fingolimod—multiple sclerosis	0.00106	0.00714	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.00105	0.00707	CcSEcCtD
Fluphenazine—CALM3—spinal cord—multiple sclerosis	0.00104	0.00655	CbGeAlD
Fluphenazine—DRD1—central nervous system—multiple sclerosis	0.00103	0.00649	CbGeAlD
Fluphenazine—Pneumonia—Cladribine—multiple sclerosis	0.00101	0.00683	CcSEcCtD
Fluphenazine—HTR2C—midbrain—multiple sclerosis	0.00101	0.00637	CbGeAlD
Fluphenazine—Dyspnoea—Fingolimod—multiple sclerosis	0.00101	0.00681	CcSEcCtD
Fluphenazine—HTR2C—spinal cord—multiple sclerosis	0.000986	0.00621	CbGeAlD
Fluphenazine—Dermatitis atopic—Prednisone—multiple sclerosis	0.000952	0.00642	CcSEcCtD
Fluphenazine—Leukocytosis—Methylprednisolone—multiple sclerosis	0.000946	0.00639	CcSEcCtD
Fluphenazine—Glaucoma—Prednisone—multiple sclerosis	0.000935	0.00631	CcSEcCtD
Fluphenazine—Renal failure acute—Mitoxantrone—multiple sclerosis	0.000929	0.00627	CcSEcCtD
Fluphenazine—CALM2—medulla oblongata—multiple sclerosis	0.000914	0.00576	CbGeAlD
Fluphenazine—CALM1—medulla oblongata—multiple sclerosis	0.00091	0.00574	CbGeAlD
Fluphenazine—Oedema peripheral—Cladribine—multiple sclerosis	0.000889	0.006	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.000886	0.00598	CcSEcCtD
Fluphenazine—Pancytopenia—Azathioprine—multiple sclerosis	0.000871	0.00588	CcSEcCtD
Fluphenazine—Leukocytosis—Betamethasone—multiple sclerosis	0.000861	0.00581	CcSEcCtD
Fluphenazine—Leukocytosis—Dexamethasone—multiple sclerosis	0.000861	0.00581	CcSEcCtD
Fluphenazine—HTR1A—midbrain—multiple sclerosis	0.00085	0.00536	CbGeAlD
Fluphenazine—CALM2—midbrain—multiple sclerosis	0.000836	0.00527	CbGeAlD
Fluphenazine—CALM1—midbrain—multiple sclerosis	0.000832	0.00524	CbGeAlD
Fluphenazine—HTR2C—nervous system—multiple sclerosis	0.000831	0.00524	CbGeAlD
Fluphenazine—HTR1A—spinal cord—multiple sclerosis	0.00083	0.00523	CbGeAlD
Fluphenazine—CALM3—cerebellum—multiple sclerosis	0.000823	0.00519	CbGeAlD
Fluphenazine—Pneumonia—Azathioprine—multiple sclerosis	0.000822	0.00555	CcSEcCtD
Fluphenazine—DRD1—brain—multiple sclerosis	0.000817	0.00515	CbGeAlD
Fluphenazine—CALM2—spinal cord—multiple sclerosis	0.000815	0.00514	CbGeAlD
Fluphenazine—CALM1—spinal cord—multiple sclerosis	0.000812	0.00512	CbGeAlD
Fluphenazine—Pruritus—Fingolimod—multiple sclerosis	0.0008	0.0054	CcSEcCtD
Fluphenazine—HTR2C—central nervous system—multiple sclerosis	0.0008	0.00504	CbGeAlD
Fluphenazine—HTR2A—brainstem—multiple sclerosis	0.000795	0.00501	CbGeAlD
Fluphenazine—Erythema—Cladribine—multiple sclerosis	0.000786	0.0053	CcSEcCtD
Fluphenazine—DRD2—midbrain—multiple sclerosis	0.000768	0.00484	CbGeAlD
Fluphenazine—HTR2A—retina—multiple sclerosis	0.000767	0.00484	CbGeAlD
Fluphenazine—Agranulocytosis—Azathioprine—multiple sclerosis	0.000763	0.00515	CcSEcCtD
Fluphenazine—Leukocytosis—Prednisone—multiple sclerosis	0.00075	0.00506	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000727	0.00491	CcSEcCtD
Fluphenazine—CYP2D6—brainstem—multiple sclerosis	0.000724	0.00457	CbGeAlD
Fluphenazine—Headache—Fingolimod—multiple sclerosis	0.000709	0.00478	CcSEcCtD
Fluphenazine—Pancytopenia—Mitoxantrone—multiple sclerosis	0.000704	0.00475	CcSEcCtD
Fluphenazine—HTR1A—nervous system—multiple sclerosis	0.000699	0.00441	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.000689	0.00465	CcSEcCtD
Fluphenazine—CALM2—nervous system—multiple sclerosis	0.000687	0.00433	CbGeAlD
Fluphenazine—CALM1—nervous system—multiple sclerosis	0.000684	0.00431	CbGeAlD
Fluphenazine—HTR1A—central nervous system—multiple sclerosis	0.000673	0.00424	CbGeAlD
Fluphenazine—Cardiac arrest—Prednisolone—multiple sclerosis	0.000669	0.00452	CcSEcCtD
Fluphenazine—CALM3—brain—multiple sclerosis	0.000669	0.00422	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000669	0.00451	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000667	0.0045	CcSEcCtD
Fluphenazine—Pneumonia—Mitoxantrone—multiple sclerosis	0.000665	0.00449	CcSEcCtD
Fluphenazine—CALM2—central nervous system—multiple sclerosis	0.000662	0.00417	CbGeAlD
Fluphenazine—Drowsiness—Mitoxantrone—multiple sclerosis	0.000661	0.00446	CcSEcCtD
Fluphenazine—CALM1—central nervous system—multiple sclerosis	0.000658	0.00415	CbGeAlD
Fluphenazine—HTR1A—cerebellum—multiple sclerosis	0.000658	0.00415	CbGeAlD
Fluphenazine—ADRA2A—medulla oblongata—multiple sclerosis	0.000652	0.00411	CbGeAlD
Fluphenazine—CALM2—cerebellum—multiple sclerosis	0.000647	0.00408	CbGeAlD
Fluphenazine—CALM1—cerebellum—multiple sclerosis	0.000644	0.00406	CbGeAlD
Fluphenazine—CYP2E1—medulla oblongata—multiple sclerosis	0.000638	0.00402	CbGeAlD
Fluphenazine—HTR2C—brain—multiple sclerosis	0.000635	0.004	CbGeAlD
Fluphenazine—DRD2—nervous system—multiple sclerosis	0.000632	0.00398	CbGeAlD
Fluphenazine—Tachycardia—Cladribine—multiple sclerosis	0.000626	0.00422	CcSEcCtD
Fluphenazine—Skin disorder—Cladribine—multiple sclerosis	0.000623	0.0042	CcSEcCtD
Fluphenazine—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.000617	0.00416	CcSEcCtD
Fluphenazine—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000615	0.00415	CcSEcCtD
Fluphenazine—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000614	0.00414	CcSEcCtD
Fluphenazine—DRD2—central nervous system—multiple sclerosis	0.000608	0.00383	CbGeAlD
Fluphenazine—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000607	0.00409	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000607	0.00409	CcSEcCtD
Fluphenazine—Hypotension—Cladribine—multiple sclerosis	0.000599	0.00405	CcSEcCtD
Fluphenazine—Lethargy—Dexamethasone—multiple sclerosis	0.000599	0.00404	CcSEcCtD
Fluphenazine—Lethargy—Betamethasone—multiple sclerosis	0.000599	0.00404	CcSEcCtD
Fluphenazine—ADRA2A—midbrain—multiple sclerosis	0.000596	0.00376	CbGeAlD
Fluphenazine—DRD2—cerebellum—multiple sclerosis	0.000594	0.00375	CbGeAlD
Fluphenazine—ADRA2A—spinal cord—multiple sclerosis	0.000582	0.00367	CbGeAlD
Fluphenazine—Leukopenia—Azathioprine—multiple sclerosis	0.000572	0.00386	CcSEcCtD
Fluphenazine—Dyspnoea—Cladribine—multiple sclerosis	0.000572	0.00386	CcSEcCtD
Fluphenazine—Somnolence—Cladribine—multiple sclerosis	0.00057	0.00385	CcSEcCtD
Fluphenazine—CYP2E1—spinal cord—multiple sclerosis	0.000569	0.00359	CbGeAlD
Fluphenazine—Asthma—Triamcinolone—multiple sclerosis	0.000559	0.00378	CcSEcCtD
Fluphenazine—Cardiac arrest—Betamethasone—multiple sclerosis	0.000558	0.00377	CcSEcCtD
Fluphenazine—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000558	0.00377	CcSEcCtD
Fluphenazine—Decreased appetite—Cladribine—multiple sclerosis	0.000557	0.00376	CcSEcCtD
Fluphenazine—HTR2A—medulla oblongata—multiple sclerosis	0.000554	0.0035	CbGeAlD
Fluphenazine—Constipation—Cladribine—multiple sclerosis	0.000548	0.0037	CcSEcCtD
Fluphenazine—HTR1A—brain—multiple sclerosis	0.000534	0.00337	CbGeAlD
Fluphenazine—Urine output increased—Methotrexate—multiple sclerosis	0.000532	0.00359	CcSEcCtD
Fluphenazine—Gynaecomastia—Methotrexate—multiple sclerosis	0.000527	0.00356	CcSEcCtD
Fluphenazine—CALM2—brain—multiple sclerosis	0.000525	0.00331	CbGeAlD
Fluphenazine—CALM1—brain—multiple sclerosis	0.000523	0.0033	CbGeAlD
Fluphenazine—Lethargy—Prednisone—multiple sclerosis	0.000522	0.00352	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00052	0.00351	CcSEcCtD
Fluphenazine—Erythema—Mitoxantrone—multiple sclerosis	0.000517	0.00349	CcSEcCtD
Fluphenazine—Urticaria—Cladribine—multiple sclerosis	0.000509	0.00344	CcSEcCtD
Fluphenazine—Body temperature increased—Cladribine—multiple sclerosis	0.000507	0.00342	CcSEcCtD
Fluphenazine—HTR2A—midbrain—multiple sclerosis	0.000507	0.0032	CbGeAlD
Fluphenazine—Skin disorder—Azathioprine—multiple sclerosis	0.000507	0.00342	CcSEcCtD
Fluphenazine—ABCB1—retina—multiple sclerosis	0.000503	0.00317	CbGeAlD
Fluphenazine—HRH1—nervous system—multiple sclerosis	0.000499	0.00314	CbGeAlD
Fluphenazine—HTR2A—spinal cord—multiple sclerosis	0.000494	0.00312	CbGeAlD
Fluphenazine—ADRA2A—nervous system—multiple sclerosis	0.00049	0.00309	CbGeAlD
Fluphenazine—Hypotension—Azathioprine—multiple sclerosis	0.000487	0.00329	CcSEcCtD
Fluphenazine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000487	0.00329	CcSEcCtD
Fluphenazine—Photosensitivity—Methotrexate—multiple sclerosis	0.000487	0.00328	CcSEcCtD
Fluphenazine—Polyuria—Methotrexate—multiple sclerosis	0.000487	0.00328	CcSEcCtD
Fluphenazine—Cardiac arrest—Prednisone—multiple sclerosis	0.000486	0.00328	CcSEcCtD
Fluphenazine—DRD2—brain—multiple sclerosis	0.000483	0.00304	CbGeAlD
Fluphenazine—HRH1—central nervous system—multiple sclerosis	0.00048	0.00303	CbGeAlD
Fluphenazine—CYP2E1—nervous system—multiple sclerosis	0.000479	0.00302	CbGeAlD
Fluphenazine—Hypersensitivity—Cladribine—multiple sclerosis	0.000472	0.00319	CcSEcCtD
Fluphenazine—ADRA2A—central nervous system—multiple sclerosis	0.000472	0.00297	CbGeAlD
Fluphenazine—Renal failure acute—Methotrexate—multiple sclerosis	0.000463	0.00312	CcSEcCtD
Fluphenazine—Leukopenia—Mitoxantrone—multiple sclerosis	0.000462	0.00312	CcSEcCtD
Fluphenazine—CYP2E1—central nervous system—multiple sclerosis	0.000462	0.00291	CbGeAlD
Fluphenazine—ADRA2A—cerebellum—multiple sclerosis	0.000461	0.00291	CbGeAlD
Fluphenazine—Pruritus—Cladribine—multiple sclerosis	0.000454	0.00306	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000453	0.00306	CcSEcCtD
Fluphenazine—CYP2E1—cerebellum—multiple sclerosis	0.000451	0.00284	CbGeAlD
Fluphenazine—Hypertension—Mitoxantrone—multiple sclerosis	0.000446	0.00301	CcSEcCtD
Fluphenazine—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000442	0.00298	CcSEcCtD
Fluphenazine—Lethargy—Methotrexate—multiple sclerosis	0.000436	0.00294	CcSEcCtD
Fluphenazine—Erythema—Prednisolone—multiple sclerosis	0.000424	0.00286	CcSEcCtD
Fluphenazine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000422	0.00285	CcSEcCtD
Fluphenazine—HTR2A—nervous system—multiple sclerosis	0.000417	0.00263	CbGeAlD
Fluphenazine—Body temperature increased—Azathioprine—multiple sclerosis	0.000412	0.00278	CcSEcCtD
Fluphenazine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000411	0.00278	CcSEcCtD
Fluphenazine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000409	0.00276	CcSEcCtD
Fluphenazine—Headache—Cladribine—multiple sclerosis	0.000402	0.00271	CcSEcCtD
Fluphenazine—HTR2A—central nervous system—multiple sclerosis	0.000401	0.00253	CbGeAlD
Fluphenazine—Vision blurred—Prednisolone—multiple sclerosis	0.000399	0.0027	CcSEcCtD
Fluphenazine—Hypotension—Mitoxantrone—multiple sclerosis	0.000394	0.00266	CcSEcCtD
Fluphenazine—HTR2A—cerebellum—multiple sclerosis	0.000392	0.00247	CbGeAlD
Fluphenazine—Erythema—Triamcinolone—multiple sclerosis	0.00039	0.00263	CcSEcCtD
Fluphenazine—Erythema—Methylprednisolone—multiple sclerosis	0.000389	0.00262	CcSEcCtD
Fluphenazine—Angioedema—Prednisolone—multiple sclerosis	0.000387	0.00261	CcSEcCtD
Fluphenazine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000384	0.00259	CcSEcCtD
Fluphenazine—HRH1—brain—multiple sclerosis	0.000381	0.0024	CbGeAlD
Fluphenazine—Nausea—Cladribine—multiple sclerosis	0.000381	0.00257	CcSEcCtD
Fluphenazine—CYP2D6—nervous system—multiple sclerosis	0.00038	0.00239	CbGeAlD
Fluphenazine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000376	0.00254	CcSEcCtD
Fluphenazine—Somnolence—Mitoxantrone—multiple sclerosis	0.000375	0.00253	CcSEcCtD
Fluphenazine—ADRA2A—brain—multiple sclerosis	0.000375	0.00236	CbGeAlD
Fluphenazine—Asthma—Methotrexate—multiple sclerosis	0.000369	0.00249	CcSEcCtD
Fluphenazine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000366	0.00247	CcSEcCtD
Fluphenazine—CYP2E1—brain—multiple sclerosis	0.000366	0.00231	CbGeAlD
Fluphenazine—Hypertension—Prednisolone—multiple sclerosis	0.000366	0.00247	CcSEcCtD
Fluphenazine—Eosinophilia—Methotrexate—multiple sclerosis	0.000366	0.00247	CcSEcCtD
Fluphenazine—CYP2D6—central nervous system—multiple sclerosis	0.000365	0.0023	CbGeAlD
Fluphenazine—ABCB1—medulla oblongata—multiple sclerosis	0.000363	0.00229	CbGeAlD
Fluphenazine—Constipation—Mitoxantrone—multiple sclerosis	0.00036	0.00243	CcSEcCtD
Fluphenazine—CYP2D6—cerebellum—multiple sclerosis	0.000357	0.00225	CbGeAlD
Fluphenazine—Triflupromazine—BCHE—multiple sclerosis	0.000356	0.316	CrCbGaD
Fluphenazine—Angioedema—Triamcinolone—multiple sclerosis	0.000356	0.0024	CcSEcCtD
Fluphenazine—Angioedema—Methylprednisolone—multiple sclerosis	0.000355	0.0024	CcSEcCtD
Fluphenazine—Erythema—Betamethasone—multiple sclerosis	0.000354	0.00239	CcSEcCtD
Fluphenazine—Erythema—Dexamethasone—multiple sclerosis	0.000354	0.00239	CcSEcCtD
Fluphenazine—Pancytopenia—Methotrexate—multiple sclerosis	0.000351	0.00237	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000346	0.00233	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000343	0.00232	CcSEcCtD
Fluphenazine—Tachycardia—Prednisolone—multiple sclerosis	0.000338	0.00228	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000337	0.00228	CcSEcCtD
Fluphenazine—Hypertension—Triamcinolone—multiple sclerosis	0.000336	0.00227	CcSEcCtD
Fluphenazine—Hypertension—Methylprednisolone—multiple sclerosis	0.000336	0.00227	CcSEcCtD
Fluphenazine—Urticaria—Mitoxantrone—multiple sclerosis	0.000335	0.00226	CcSEcCtD
Fluphenazine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000333	0.00225	CcSEcCtD
Fluphenazine—ABCB1—midbrain—multiple sclerosis	0.000332	0.00209	CbGeAlD
Fluphenazine—Pneumonia—Methotrexate—multiple sclerosis	0.000331	0.00224	CcSEcCtD
Fluphenazine—Drowsiness—Methotrexate—multiple sclerosis	0.000329	0.00222	CcSEcCtD
Fluphenazine—Headache—Azathioprine—multiple sclerosis	0.000327	0.00221	CcSEcCtD
Fluphenazine—Dry mouth—Triamcinolone—multiple sclerosis	0.000324	0.00219	CcSEcCtD
Fluphenazine—ABCB1—spinal cord—multiple sclerosis	0.000324	0.00204	CbGeAlD
Fluphenazine—Angioedema—Dexamethasone—multiple sclerosis	0.000323	0.00218	CcSEcCtD
Fluphenazine—Angioedema—Betamethasone—multiple sclerosis	0.000323	0.00218	CcSEcCtD
Fluphenazine—HTR2A—brain—multiple sclerosis	0.000318	0.00201	CbGeAlD
Fluphenazine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000318	0.00215	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000317	0.00214	CcSEcCtD
Fluphenazine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000311	0.0021	CcSEcCtD
Fluphenazine—Tachycardia—Triamcinolone—multiple sclerosis	0.00031	0.0021	CcSEcCtD
Fluphenazine—Nausea—Azathioprine—multiple sclerosis	0.00031	0.00209	CcSEcCtD
Fluphenazine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00031	0.00209	CcSEcCtD
Fluphenazine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000308	0.00208	CcSEcCtD
Fluphenazine—Erythema—Prednisone—multiple sclerosis	0.000308	0.00208	CcSEcCtD
Fluphenazine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000307	0.00207	CcSEcCtD
Fluphenazine—Hypertension—Dexamethasone—multiple sclerosis	0.000305	0.00206	CcSEcCtD
Fluphenazine—Hypertension—Betamethasone—multiple sclerosis	0.000305	0.00206	CcSEcCtD
Fluphenazine—Hypotension—Methylprednisolone—multiple sclerosis	0.000297	0.002	CcSEcCtD
Fluphenazine—Vision blurred—Prednisone—multiple sclerosis	0.00029	0.00196	CcSEcCtD
Fluphenazine—CYP2D6—brain—multiple sclerosis	0.00029	0.00183	CbGeAlD
Fluphenazine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000289	0.00195	CcSEcCtD
Fluphenazine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000289	0.00195	CcSEcCtD
Fluphenazine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000284	0.00191	CcSEcCtD
Fluphenazine—Agitation—Prednisone—multiple sclerosis	0.000283	0.00191	CcSEcCtD
Fluphenazine—Tachycardia—Dexamethasone—multiple sclerosis	0.000282	0.0019	CcSEcCtD
Fluphenazine—Tachycardia—Betamethasone—multiple sclerosis	0.000282	0.0019	CcSEcCtD
Fluphenazine—Angioedema—Prednisone—multiple sclerosis	0.000281	0.0019	CcSEcCtD
Fluphenazine—Urticaria—Prednisolone—multiple sclerosis	0.000275	0.00185	CcSEcCtD
Fluphenazine—ABCB1—nervous system—multiple sclerosis	0.000273	0.00172	CbGeAlD
Fluphenazine—Hypotension—Betamethasone—multiple sclerosis	0.00027	0.00182	CcSEcCtD
Fluphenazine—Hypotension—Dexamethasone—multiple sclerosis	0.00027	0.00182	CcSEcCtD
Fluphenazine—Hypertension—Prednisone—multiple sclerosis	0.000266	0.00179	CcSEcCtD
Fluphenazine—Headache—Mitoxantrone—multiple sclerosis	0.000264	0.00178	CcSEcCtD
Fluphenazine—ABCB1—central nervous system—multiple sclerosis	0.000263	0.00166	CbGeAlD
Fluphenazine—Erythema—Methotrexate—multiple sclerosis	0.000257	0.00174	CcSEcCtD
Fluphenazine—ABCB1—cerebellum—multiple sclerosis	0.000257	0.00162	CbGeAlD
Fluphenazine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000255	0.00172	CcSEcCtD
Fluphenazine—Urticaria—Triamcinolone—multiple sclerosis	0.000253	0.00171	CcSEcCtD
Fluphenazine—Urticaria—Methylprednisolone—multiple sclerosis	0.000252	0.0017	CcSEcCtD
Fluphenazine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000251	0.0017	CcSEcCtD
Fluphenazine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000251	0.0017	CcSEcCtD
Fluphenazine—Decreased appetite—Betamethasone—multiple sclerosis	0.000251	0.00169	CcSEcCtD
Fluphenazine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000251	0.00169	CcSEcCtD
Fluphenazine—Nausea—Mitoxantrone—multiple sclerosis	0.00025	0.00169	CcSEcCtD
Fluphenazine—Tachycardia—Prednisone—multiple sclerosis	0.000245	0.00166	CcSEcCtD
Fluphenazine—Skin disorder—Prednisone—multiple sclerosis	0.000244	0.00165	CcSEcCtD
Fluphenazine—Vision blurred—Methotrexate—multiple sclerosis	0.000243	0.00164	CcSEcCtD
Fluphenazine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000234	0.00158	CcSEcCtD
Fluphenazine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000234	0.00158	CcSEcCtD
Fluphenazine—Leukopenia—Methotrexate—multiple sclerosis	0.00023	0.00155	CcSEcCtD
Fluphenazine—Urticaria—Betamethasone—multiple sclerosis	0.000229	0.00155	CcSEcCtD
Fluphenazine—Urticaria—Dexamethasone—multiple sclerosis	0.000229	0.00155	CcSEcCtD
Fluphenazine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000228	0.00154	CcSEcCtD
Fluphenazine—Body temperature increased—Betamethasone—multiple sclerosis	0.000228	0.00154	CcSEcCtD
Fluphenazine—Pruritus—Triamcinolone—multiple sclerosis	0.000225	0.00152	CcSEcCtD
Fluphenazine—Pruritus—Methylprednisolone—multiple sclerosis	0.000225	0.00152	CcSEcCtD
Fluphenazine—Decreased appetite—Prednisone—multiple sclerosis	0.000218	0.00147	CcSEcCtD
Fluphenazine—Headache—Prednisolone—multiple sclerosis	0.000217	0.00146	CcSEcCtD
Fluphenazine—Constipation—Prednisone—multiple sclerosis	0.000215	0.00145	CcSEcCtD
Fluphenazine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00021	0.00142	CcSEcCtD
Fluphenazine—ABCB1—brain—multiple sclerosis	0.000209	0.00132	CbGeAlD
Fluphenazine—Nausea—Prednisolone—multiple sclerosis	0.000205	0.00139	CcSEcCtD
Fluphenazine—Pruritus—Dexamethasone—multiple sclerosis	0.000204	0.00138	CcSEcCtD
Fluphenazine—Pruritus—Betamethasone—multiple sclerosis	0.000204	0.00138	CcSEcCtD
Fluphenazine—Skin disorder—Methotrexate—multiple sclerosis	0.000204	0.00138	CcSEcCtD
Fluphenazine—Urticaria—Prednisone—multiple sclerosis	0.0002	0.00135	CcSEcCtD
Fluphenazine—Headache—Triamcinolone—multiple sclerosis	0.000199	0.00134	CcSEcCtD
Fluphenazine—Headache—Methylprednisolone—multiple sclerosis	0.000199	0.00134	CcSEcCtD
Fluphenazine—Body temperature increased—Prednisone—multiple sclerosis	0.000199	0.00134	CcSEcCtD
Fluphenazine—Hypotension—Methotrexate—multiple sclerosis	0.000196	0.00132	CcSEcCtD
Fluphenazine—Nausea—Triamcinolone—multiple sclerosis	0.000189	0.00128	CcSEcCtD
Fluphenazine—Nausea—Methylprednisolone—multiple sclerosis	0.000188	0.00127	CcSEcCtD
Fluphenazine—Dyspnoea—Methotrexate—multiple sclerosis	0.000187	0.00126	CcSEcCtD
Fluphenazine—Somnolence—Methotrexate—multiple sclerosis	0.000187	0.00126	CcSEcCtD
Fluphenazine—Hypersensitivity—Prednisone—multiple sclerosis	0.000185	0.00125	CcSEcCtD
Fluphenazine—Decreased appetite—Methotrexate—multiple sclerosis	0.000183	0.00123	CcSEcCtD
Fluphenazine—Headache—Betamethasone—multiple sclerosis	0.000181	0.00122	CcSEcCtD
Fluphenazine—Headache—Dexamethasone—multiple sclerosis	0.000181	0.00122	CcSEcCtD
Fluphenazine—Pruritus—Prednisone—multiple sclerosis	0.000178	0.0012	CcSEcCtD
Fluphenazine—Chlorpromazine—BCHE—multiple sclerosis	0.000172	0.153	CrCbGaD
Fluphenazine—Nausea—Betamethasone—multiple sclerosis	0.000171	0.00116	CcSEcCtD
Fluphenazine—Nausea—Dexamethasone—multiple sclerosis	0.000171	0.00116	CcSEcCtD
Fluphenazine—Urticaria—Methotrexate—multiple sclerosis	0.000167	0.00113	CcSEcCtD
Fluphenazine—Body temperature increased—Methotrexate—multiple sclerosis	0.000166	0.00112	CcSEcCtD
Fluphenazine—Headache—Prednisone—multiple sclerosis	0.000157	0.00106	CcSEcCtD
Fluphenazine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000155	0.00104	CcSEcCtD
Fluphenazine—Nausea—Prednisone—multiple sclerosis	0.000149	0.00101	CcSEcCtD
Fluphenazine—Pruritus—Methotrexate—multiple sclerosis	0.000149	0.001	CcSEcCtD
Fluphenazine—Acepromazine—ALB—multiple sclerosis	0.000135	0.12	CrCbGaD
Fluphenazine—Thioproperazine—ALB—multiple sclerosis	0.000132	0.117	CrCbGaD
Fluphenazine—Headache—Methotrexate—multiple sclerosis	0.000132	0.000888	CcSEcCtD
Fluphenazine—Thiothixene—ALB—multiple sclerosis	0.00013	0.116	CrCbGaD
Fluphenazine—Pipotiazine—ALB—multiple sclerosis	0.00013	0.116	CrCbGaD
Fluphenazine—Nausea—Methotrexate—multiple sclerosis	0.000125	0.000842	CcSEcCtD
Fluphenazine—Chlorpromazine—ALB—multiple sclerosis	7.06e-05	0.0626	CrCbGaD
Fluphenazine—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.26e-05	6.5e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.26e-05	6.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—TYK2—multiple sclerosis	1.25e-05	6.45e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—TYK2—multiple sclerosis	1.25e-05	6.45e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CD80—multiple sclerosis	1.25e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CD80—multiple sclerosis	1.25e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—MAPK1—multiple sclerosis	1.25e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—MAPK1—multiple sclerosis	1.25e-05	6.44e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CD86—multiple sclerosis	1.24e-05	6.39e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.24e-05	6.39e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.24e-05	6.38e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.23e-05	6.31e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.22e-05	6.3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL5—multiple sclerosis	1.22e-05	6.29e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.21e-05	6.21e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.21e-05	6.21e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—APOE—multiple sclerosis	1.21e-05	6.21e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.21e-05	6.2e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—APOE—multiple sclerosis	1.2e-05	6.2e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CD86—multiple sclerosis	1.2e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.2e-05	6.18e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL2—multiple sclerosis	1.2e-05	6.17e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—APOE—multiple sclerosis	1.2e-05	6.17e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.19e-05	6.15e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	1.19e-05	6.14e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.19e-05	6.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—TYK2—multiple sclerosis	1.18e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL5—multiple sclerosis	1.18e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL5—multiple sclerosis	1.18e-05	6.09e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.18e-05	6.08e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.17e-05	6.04e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.17e-05	6.01e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—APOE—multiple sclerosis	1.16e-05	5.97e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—APOE—multiple sclerosis	1.16e-05	5.97e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.15e-05	5.91e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—TYK2—multiple sclerosis	1.14e-05	5.89e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—TYK2—multiple sclerosis	1.14e-05	5.89e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.14e-05	5.88e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	1.13e-05	5.84e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SPP1—multiple sclerosis	1.13e-05	5.83e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—POMC—multiple sclerosis	1.13e-05	5.81e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	5.71e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IFNG—multiple sclerosis	1.11e-05	5.7e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCR5—multiple sclerosis	1.1e-05	5.67e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.1e-05	5.65e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	5.64e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SPP1—multiple sclerosis	1.1e-05	5.64e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TYK2—multiple sclerosis	1.09e-05	5.62e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.09e-05	5.62e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CD80—multiple sclerosis	1.09e-05	5.6e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2RA—multiple sclerosis	1.09e-05	5.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL2—multiple sclerosis	1.08e-05	5.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IFNG—multiple sclerosis	1.07e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IFNG—multiple sclerosis	1.07e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—CD4—multiple sclerosis	1.07e-05	5.51e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.07e-05	5.49e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	5.48e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCR5—multiple sclerosis	1.07e-05	5.48e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.06e-05	5.46e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TYK2—multiple sclerosis	1.06e-05	5.44e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TYK2—multiple sclerosis	1.06e-05	5.44e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	5.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2RA—multiple sclerosis	1.05e-05	5.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL2—multiple sclerosis	1.04e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL2—multiple sclerosis	1.04e-05	5.36e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.04e-05	5.34e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.04e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—CD4—multiple sclerosis	1.03e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—CD4—multiple sclerosis	1.03e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—POMC—multiple sclerosis	1.03e-05	5.33e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.03e-05	5.31e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.03e-05	5.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—POMC—multiple sclerosis	1.03e-05	5.3e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ALB—multiple sclerosis	1.03e-05	5.29e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.03e-05	5.28e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	5.24e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.01e-05	5.22e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.01e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	1.01e-05	5.21e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	5.19e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	1.01e-05	5.19e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—APOE—multiple sclerosis	1e-05	5.16e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—POMC—multiple sclerosis	9.96e-06	5.13e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—POMC—multiple sclerosis	9.96e-06	5.13e-05	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—multiple sclerosis	9.93e-06	5.11e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	9.93e-06	5.11e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.93e-06	5.11e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	9.9e-06	5.1e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL1B—multiple sclerosis	9.88e-06	5.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—CD4—multiple sclerosis	9.88e-06	5.08e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL2—multiple sclerosis	9.84e-06	5.07e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MMP9—multiple sclerosis	9.77e-06	5.03e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—APOE—multiple sclerosis	9.69e-06	4.99e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—APOE—multiple sclerosis	9.69e-06	4.99e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MMP9—multiple sclerosis	9.64e-06	4.96e-05	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—multiple sclerosis	9.61e-06	4.95e-05	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—multiple sclerosis	9.61e-06	4.95e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL1B—multiple sclerosis	9.56e-06	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL1B—multiple sclerosis	9.56e-06	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—CD4—multiple sclerosis	9.55e-06	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—CD4—multiple sclerosis	9.55e-06	4.92e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL2—multiple sclerosis	9.52e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL2—multiple sclerosis	9.52e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ALB—multiple sclerosis	9.44e-06	4.86e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	9.43e-06	4.86e-05	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ALB—multiple sclerosis	9.38e-06	4.83e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MYC—multiple sclerosis	9.37e-06	4.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	9.36e-06	4.82e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	9.35e-06	4.81e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	9.23e-06	4.75e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	9.21e-06	4.74e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	9.19e-06	4.73e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	9.17e-06	4.72e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—APOE—multiple sclerosis	9.08e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ALB—multiple sclerosis	9.08e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ALB—multiple sclerosis	9.08e-06	4.67e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CD80—multiple sclerosis	9.06e-06	4.66e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	9.03e-06	4.65e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL2—multiple sclerosis	8.87e-06	4.57e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	8.83e-06	4.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	8.83e-06	4.54e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	8.78e-06	4.52e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CD80—multiple sclerosis	8.76e-06	4.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CD80—multiple sclerosis	8.76e-06	4.51e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—STAT3—multiple sclerosis	8.68e-06	4.47e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—POMC—multiple sclerosis	8.61e-06	4.43e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—STAT3—multiple sclerosis	8.57e-06	4.41e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—APOE—multiple sclerosis	8.56e-06	4.4e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—CCL2—multiple sclerosis	8.42e-06	4.33e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	8.4e-06	4.32e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	8.38e-06	4.31e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	8.35e-06	4.3e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—POMC—multiple sclerosis	8.33e-06	4.29e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—POMC—multiple sclerosis	8.33e-06	4.29e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—STAT3—multiple sclerosis	8.28e-06	4.26e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—MAPK1—multiple sclerosis	8.24e-06	4.24e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—CCL2—multiple sclerosis	8.15e-06	4.19e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—CCL2—multiple sclerosis	8.15e-06	4.19e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MYC—multiple sclerosis	8.07e-06	4.15e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.05e-06	4.14e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—STAT3—multiple sclerosis	8.01e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—STAT3—multiple sclerosis	8.01e-06	4.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.97e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—MAPK1—multiple sclerosis	7.97e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MYC—multiple sclerosis	7.96e-06	4.1e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	7.94e-06	4.09e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	7.89e-06	4.06e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—POMC—multiple sclerosis	7.8e-06	4.02e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.79e-06	4.01e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	7.79e-06	4.01e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.75e-06	3.99e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	7.67e-06	3.95e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL2—multiple sclerosis	7.65e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TYK2—multiple sclerosis	7.65e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—STAT3—multiple sclerosis	7.65e-06	3.94e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	7.63e-06	3.93e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	7.61e-06	3.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—MAPK1—multiple sclerosis	7.53e-06	3.88e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	7.47e-06	3.84e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	7.43e-06	3.82e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TYK2—multiple sclerosis	7.4e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TYK2—multiple sclerosis	7.4e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—STAT3—multiple sclerosis	7.4e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—STAT3—multiple sclerosis	7.4e-06	3.81e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	7.37e-06	3.8e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—POMC—multiple sclerosis	7.35e-06	3.78e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—MAPK1—multiple sclerosis	7.28e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—MAPK1—multiple sclerosis	7.28e-06	3.75e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	7.25e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—APOE—multiple sclerosis	7.25e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	7.24e-06	3.73e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ALB—multiple sclerosis	7.11e-06	3.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MYC—multiple sclerosis	7.11e-06	3.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TGFB1—multiple sclerosis	7.09e-06	3.65e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—multiple sclerosis	7.05e-06	3.63e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	6.97e-06	3.59e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—MAPK1—multiple sclerosis	6.95e-06	3.58e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	6.94e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MYC—multiple sclerosis	6.94e-06	3.57e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	6.92e-06	3.56e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	6.9e-06	3.55e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	6.89e-06	3.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MYC—multiple sclerosis	6.87e-06	3.54e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MYC—multiple sclerosis	6.87e-06	3.54e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TGFB1—multiple sclerosis	6.86e-06	3.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TGFB1—multiple sclerosis	6.86e-06	3.53e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	6.79e-06	3.49e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	6.75e-06	3.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—MAPK1—multiple sclerosis	6.72e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—MAPK1—multiple sclerosis	6.72e-06	3.46e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ALB—multiple sclerosis	6.7e-06	3.45e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	6.6e-06	3.4e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.56e-06	3.37e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	6.45e-06	3.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	6.44e-06	3.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL2—multiple sclerosis	6.36e-06	3.28e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—multiple sclerosis	6.33e-06	3.26e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—POMC—multiple sclerosis	6.23e-06	3.21e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL2—multiple sclerosis	6.16e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL2—multiple sclerosis	6.16e-06	3.17e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—multiple sclerosis	6.12e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—multiple sclerosis	6.12e-06	3.15e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.09e-06	3.14e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.08e-06	3.13e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—multiple sclerosis	6.07e-06	3.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MMP9—multiple sclerosis	6.02e-06	3.1e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	5.99e-06	3.09e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—multiple sclerosis	5.98e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MYC—multiple sclerosis	5.98e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	5.98e-06	3.08e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	5.97e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	5.96e-06	3.07e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	5.87e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	5.86e-06	3.02e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	5.85e-06	3.01e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MMP9—multiple sclerosis	5.83e-06	3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MMP9—multiple sclerosis	5.83e-06	3e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—multiple sclerosis	5.78e-06	2.98e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ALB—multiple sclerosis	5.68e-06	2.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—multiple sclerosis	5.6e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—multiple sclerosis	5.6e-06	2.88e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	5.45e-06	2.81e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	5.44e-06	2.8e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—STAT3—multiple sclerosis	5.35e-06	2.76e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—multiple sclerosis	5.34e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.33e-06	2.75e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.22e-06	2.68e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	5.19e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—STAT3—multiple sclerosis	5.18e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—STAT3—multiple sclerosis	5.18e-06	2.67e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—multiple sclerosis	5.17e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—multiple sclerosis	5.17e-06	2.66e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MYC—multiple sclerosis	4.98e-06	2.56e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TGFB1—multiple sclerosis	4.96e-06	2.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—MAPK1—multiple sclerosis	4.87e-06	2.51e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MYC—multiple sclerosis	4.81e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MYC—multiple sclerosis	4.81e-06	2.48e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TGFB1—multiple sclerosis	4.8e-06	2.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TGFB1—multiple sclerosis	4.8e-06	2.47e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—MAPK1—multiple sclerosis	4.71e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—MAPK1—multiple sclerosis	4.71e-06	2.42e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.58e-06	2.36e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	4.51e-06	2.32e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—multiple sclerosis	4.5e-06	2.31e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.1e-06	2.11e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—multiple sclerosis	3.74e-06	1.93e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—multiple sclerosis	3.62e-06	1.86e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—multiple sclerosis	3.62e-06	1.86e-05	CbGpPWpGaD
